RNS Number : 3400W
Stenprop Limited
31 July 2018
STENPROP LIMITED
(Registered in Guernsey)
(Registration number 64865)
LSE share code: STP JSE share code: STP
ISIN: GG00BFWMR296
("Stenprop" or the "Company")
DEALINGS IN SECURITIES BY A DIRECTOR, ASSOCIATES OF DIRECTORS, A DIRECTOR OF MAJOR SUBSIDIARIES AND AN ASSOCIATE OF A DIRECTOR OF MAJOR SUBSIDIARIES OF THE COMPANY
31 July 2018
Shareholders are advised of the following information relating to dealings in securities by a director and associates of directors of the Company; and by a director of major subsidiaries and an associate of a director of major subsidiaries of Stenprop, pursuant to the declaration of a cash dividend for the six months ended 31 March 2018 with an election to receive a scrip dividend in lieu of cash ("scrip dividend") in accordance with the circular issued to shareholders on 10 July 2018. Clearance to deal was granted in respect of all shares allocated in terms of the scrip dividend:
Name of director: | Paul Arenson |
Transaction date: | 30 July 2018 |
Class of securities: | Ordinary shares |
Number of securities: | 14,122 |
Price per security: | GPB 1.1330 |
Total value: | GPB 16,000.23 |
Nature of transaction: | Off-market receipt of shares pursuant to an election to receive the scrip dividend through SP Nominees, a nominee company which holds shares on behalf of Paul Arenson |
Nature and extent of director's interest: | Direct beneficial |
Name of associate: | Jabali Enterprises Limited |
Name of director and relationship to director: | Paul Arenson, who is a discretionary beneficiary of the Lonat Trust which has a beneficial interest in Jabali Enterprises Limited |
Transaction date: | 30 July 2018 |
Class of securities: | Ordinary shares |
Number of securities: | 190,381 |
Price per security: | GPB 1.1330 |
Total value: | GPB 215,701.67 |
Nature of transaction: | Off-market receipt of shares pursuant to an election to receive the scrip dividend through SP Nominees, a nominee company which holds shares on behalf of Jabali Enterprises Limited |
Nature and extent of director's interest: | Indirect beneficial |
Name of associate: | Zowert Properties Limited |
Name of director and relationship to director: | Paul Arenson, who is a discretionary beneficiary of the Saruga Trust, which has a beneficial interest in Zowert Properties Limited |
Transaction date: | 30 July 2018 |
Class of securities: | Ordinary shares |
Number of securities: | 58,944 |
Price per security: | GPB 1.1330 |
Total value: | GPB 66,783.55 |
Nature of transaction: | Off-market receipt of shares pursuant to an election to receive the scrip dividend through SP Nominees, a nominee company which holds shares on behalf of Zowert Properties Limited |
Nature and extent of director's interest: | Indirect beneficial |
Name of associate: | Lonat Trust |
Name of director and relationship to director: | Paul Arenson, who is a discretionary beneficiary of the Lonat Trust |
Transaction date: | 30 July 2018 |
Class of securities: | Ordinary shares |
Number of securities: | 70,868 |
Price per security: | GPB 1.1330 |
Total value: | GPB 80,2943.44 |
Nature of transaction: | Off-market receipt of shares pursuant to an election to receive the scrip dividend through SP Nominees, a nominee company which holds shares on behalf of the Lonat Trust |
Nature and extent of director's interest: | Indirect beneficial |
Name of associate: | Saruga Trust |
Name of director and relationship to director: | Paul Arenson, who is a discretionary beneficiary of the Saruga Trust |
Transaction date: | 30 July 2018 |
Class of securities: | Ordinary shares |
Number of securities: | 107,807 |
Price per security: | GPB 1.1330 |
Total value: | GPB 122,145.33 |
Nature of transaction: | Off-market receipt of shares pursuant to an election to receive the scrip dividend through SP Nominees, a nominee company which holds shares on behalf of Saruga Trust |
Nature and extent of director's interest: | Indirect beneficial |
Name of associate: | Millicent Limited |
Name of director and relationship to director: | Patsy Watson, who is a discretionary beneficiary of the Swallow Trust which has a beneficial interest in Millicent Limited |
Transaction date: | 30 July 2018 |
Class of securities: | Ordinary shares |
Number of securities: | 154,070 |
Price per security: | GPB 1.1330 |
Total value: | GPB 174,561.31 |
Nature of transaction: | Off-market receipt of shares pursuant to an election to receive the scrip dividend through SP Nominees, a nominee company which holds shares on behalf of Millicent Limited |
Nature and extent of director's interest: | Indirect beneficial |
Name of associate: | Ferryman Capital Partners Limited |
Name of director and relationship to director: | Warren Lawlor, who is a beneficiary of the Warren Lawlor Family Trust, which has a beneficial interest in Ferryman Capital Partners Limited |
Transaction date: | 30 July 2018 |
Class of securities: | Ordinary shares |
Number of securities: | 28,369 |
Price per security: | GPB 1.1330 |
Total value: | £32,142.08 |
Nature of transaction: | Off-market receipt of shares pursuant to an election to receive the scrip dividend through SP Nominees, a nominee company which holds shares on behalf of Ferryman Capital Partners Limited |
Nature and extent of director's interest: | Indirect beneficial |
Name of associate: | Pringlelight Investments Proprietary Limited |
Name of director and relationship to director: | Warren Lawlor, who is the sole director of Pringlelight Investments Proprietary Limited and a beneficiary of the Warren Lawlor Family Trust which has a beneficial interest in Pringlelight Investments Proprietary Limited |
Transaction date: | 27 July 2018 |
Class of securities: | Ordinary shares |
Number of securities: | 746 |
Price per security: | GPB 1.1330 |
Total value: | £845.22 |
Nature of transaction: | Off-market receipt of shares pursuant to an election to receive the scrip dividend |
Nature and extent of director's interest: | Indirect beneficial |
Name of associate: | Sphere Investments Limited |
Name of director and relationship to director: | Stephen Ball, who is a director of Stenprop (UK) Limited, Stenprop (Germany) Limited, Stenprop (Swiss) Limited and Stenprop Trafalgar Limited, being subsidiaries of Stenprop. Stephen Ball has a beneficial interest in Sphere Investments Limited |
Transaction date: | 30 July 2018 |
Class of securities: | Ordinary shares |
Number of securities: | 8,826 |
Price per security: | GPB 1.1330 |
Total value: | GPB 9,999.86 |
Nature of transaction: | Off-market receipt of shares pursuant to an election to receive the scrip dividend through SP Nominees, a nominee company which holds shares on behalf of Sphere Investments Limited |
Nature and extent of director's interest: | Indirect beneficial |
Name of associate: | Sphere Investments Limited |
Name of director and relationship to director: | Stephen Ball, who is a director of Stenprop (UK) Limited, Stenprop (Germany) Limited, Stenprop (Swiss) Limited and Stenprop Trafalgar Limited, being subsidiaries of Stenprop. Stephen Ball has a beneficial interest in Sphere Investments Limited |
Transaction date: | 30 July 2018 |
Class of securities: | Ordinary shares |
Number of securities: | 1,059 |
Price per security: | GPB 1.1330 |
Total value: | GPB 1,199.85 |
Nature of transaction: | Off-market receipt of shares pursuant to an election to receive the scrip dividend |
Nature and extent of director's interest: | Indirect beneficial |
|
|
Name of director: | Neil Marais, who is a director of Stenprop (UK) Limited, Stenprop (Germany) Limited, Stenprop (Swiss) Limited and Stenprop Trafalgar Limited, being subsidiaries of Stenprop. |
Transaction date: | 30 July 2018 |
Class of securities: | Ordinary shares |
Number of securities: | 532 |
Price per security: | GPB 1.1330 |
Total value: | GPB 602.76 |
Nature of transaction: | Off-market receipt of shares pursuant to an election to receive the scrip dividend |
Nature and extent of director's interest: | Direct beneficial |
Shareholders are further advised of the following on-market purchase of shares by an associate of a director of Stenprop (UK) Limited, Stenprop (Germany) Limited, Stenprop (Swiss) Limited and Stenprop Trafalgar Limited, being subsidiaries of Stenprop:
Name of associate: | Sphere Investments Limited |
Name of director and relationship to director: | Stephen Ball, who is a director of Stenprop (UK) Limited, Stenprop (Germany) Limited, Stenprop (Swiss) Limited and Stenprop Trafalgar Limited, being subsidiaries of Stenprop. Stephen Ball has a beneficial interest in Sphere Investments Limited |
Transaction date: | 13 July 2018 |
Class of securities: | Ordinary shares |
Number of securities: | 30,000 |
Price per security: | GPB 1.1800 |
Total value: | GPB 35,400.00 |
Nature of transaction: | On-market purchase of shares |
Nature and extent of director's interest: | Indirect beneficial |
Clearance to deal: | N/A as the purchase of shares was undertaken by a portfolio manager |
Enquiries:
Stenprop Limited Paul Arenson | 44(0)20 7079 6600 |
Numis Securities Limited (Financial Adviser) Hugh Jonathan | 44(0)20 7260 1000 |
Tavistock (PR adviser) James Whitmore James Verstringhe Kirsty Allan | 44(0)20 7920 3150 |
|
|
|
Instinctif Partners (SA Investor Relations and PR Adviser) | 27 (0)11 447 3030 |
Keagile Makgoba |
|
|
Java Capital Trustees and Sponsors Proprietary Limited (JSE Sponsor)
| 27 (0) 11 722 3050 |
About Stenprop
Stenprop is a Guernsey-registered UK REIT. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial ("MLI") properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to www.stenprop.com.
Stenprop has a listing on the Specialist Fund Segment of the main market of the LSE and a primary listing on the Main Board of the JSE.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.